Pfizer has been involved in developing treatments for obesity, including investigational weight loss drugs. If you are wondering, “does pfizer make a weight loss drug,” the answer is not a simple yes or no—they have several candidates in their pipeline, but none are on the market yet. This article breaks down everything you need to know about Pfizer’s efforts in the weight loss space, from their current research to what might be coming next.
Does Pfizer Make A Weight Loss Drug
Right now, Pfizer does not sell a weight loss drug that you can buy at a pharmacy. Their focus is on developing new medications that target obesity and related conditions. The company has two main candidates: danuglipron and lotiglipron. These are experimental drugs designed to help people lose weight by mimicking hormones that control appetite.
Pfizer’s work in this area is part of a larger trend. Many drug companies are racing to create effective weight loss treatments. But Pfizer is still in the testing phase. They have not yet submitted any of these drugs for approval by the FDA or other health agencies.
Why Pfizer Entered The Weight Loss Market
Obesity is a global health crisis. Millions of people struggle with their weight, and many need medical help. Pfizer saw an opportunity to develop treatments that could make a real difference. Their research focuses on GLP-1 receptor agonists, which are similar to drugs like Ozempic and Wegovy.
These drugs work by slowing digestion and reducing appetite. Pfizer believes their versions could be more convenient. For example, some of their candidates are taken as a pill, not an injection. This could make them easier for patients to use.
Current Status Of Pfizer’s Weight Loss Drugs
Pfizer has two main weight loss drugs in clinical trials. Danuglipron is a GLP-1 agonist taken twice daily. Lotiglipron is another GLP-1 agonist, but it is taken once daily. Both are still being tested for safety and effectiveness.
In late 2023, Pfizer reported mixed results from early trials. Some participants lost significant weight, but others had side effects like nausea and vomiting. The company is now adjusting the formulas to reduce these issues. They hope to move into larger trials soon.
Pfizer also has a drug called PF-07081532, which targets a different hormone pathway. This one is in earlier stages of development. It is not yet clear if it will work as well as the GLP-1 drugs.
Key Differences Between Pfizer’s Candidates
- Danuglipron: Twice-daily pill, strong weight loss results, more side effects
- Lotiglipron: Once-daily pill, milder side effects, slightly less weight loss
- PF-07081532: Targets different hormone, early stage research
How Pfizer’s Drugs Compare To Competitors
You might know about drugs like Ozempic, Wegovy, and Mounjaro. These are already approved for weight loss or diabetes. Pfizer’s drugs are similar but not identical. The main difference is that Pfizer’s are pills, while most competitors are injections.
This could be a big advantage. Many people dislike needles. A pill form might make weight loss treatment more accessible. However, Pfizer’s drugs are still in trials. They have not proven they are as effective as the injectable options.
Another difference is cost. Pfizer has not announced pricing yet. But they might try to offer a lower price to compete with established brands. This could help more people afford treatment.
Potential Timeline For FDA Approval
Pfizer’s weight loss drugs are not close to approval. The company is still in Phase 2 trials. After that, they need Phase 3 trials, which can take years. If everything goes well, the earliest possible approval might be 2026 or later.
There are no guarantees. Many drugs fail in late-stage trials. Pfizer might decide to stop development if the results are not good enough. You should not expect to see a Pfizer weight loss drug on shelves anytime soon.
What This Means For You
If you are looking for a weight loss drug right now, Pfizer is not an option. You should talk to your doctor about approved treatments. Drugs like Wegovy and Saxenda are available with a prescription. They have proven safety records and are covered by many insurance plans.
Pfizer’s drugs might be worth watching in the future. But for now, stick with what is proven. Your doctor can help you decide if a weight loss drug is right for you.
How Pfizer’s Weight Loss Drugs Work
Pfizer’s weight loss drugs target the same biological pathways as other GLP-1 agonists. These drugs mimic a hormone called glucagon-like peptide-1. This hormone tells your brain that you are full. It also slows down how fast your stomach empties food.
When you take a GLP-1 drug, you feel less hungry. You eat less food, and you feel full longer. Over time, this leads to weight loss. The effect is similar to what happens with Ozempic or Wegovy.
Pfizer’s drugs are different because they are small molecules. This means they can be taken as a pill. Most other GLP-1 drugs are peptides, which require injection. The pill form could be more convenient for daily use.
Side Effects You Should Know About
Like all GLP-1 drugs, Pfizer’s candidates have side effects. The most common ones are nausea, vomiting, diarrhea, and constipation. These happen because the drug slows down your digestive system.
In Pfizer’s trials, some participants had more serious side effects. These included pancreatitis and gallbladder issues. The company is monitoring these risks closely. They are adjusting the doses to find a balance between effectiveness and safety.
You should never take an experimental drug without medical supervision. If Pfizer’s drugs become available, your doctor will explain the risks and benefits.
Who Might Benefit From These Drugs
Pfizer’s weight loss drugs are designed for people with obesity. This usually means a body mass index (BMI) of 30 or higher. They might also be for people with a BMI of 27 or higher who have weight-related health problems, like diabetes or high blood pressure.
The drugs are not for cosmetic weight loss. They are meant to treat a medical condition. Pfizer will likely follow the same guidelines as other weight loss drugs. You would need a prescription from your doctor.
Other Pfizer Drugs That Affect Weight
Pfizer makes many other medications. Some of them can cause weight gain or weight loss as a side effect. For example, certain antidepressants and antipsychotics can lead to weight gain. Pfizer does not market these as weight loss drugs.
One Pfizer drug that sometimes causes weight loss is Chantix, which is used to quit smoking. Some people lose weight when they stop smoking, but this is not the main purpose of the drug.
Pfizer also makes a drug called Xeljanz for rheumatoid arthritis. Weight changes are possible but not common. None of these are alternatives to a dedicated weight loss treatment.
Why Pfizer Is Not Selling A Weight Loss Drug Yet
Developing a new drug is a long and expensive process. Pfizer has to prove that their drugs are safe and effective. This requires years of testing with thousands of patients. The FDA then reviews the data before approving anything.
Pfizer also faces competition from other companies. Novo Nordisk and Eli Lilly already have successful weight loss drugs. Pfizer needs to show that their drugs are just as good, or better, to get a share of the market.
There is also the challenge of manufacturing. Making pills is different from making injectable drugs. Pfizer has to scale up production if their trials succeed. This takes time and money.
What The Future Holds For Pfizer Weight Loss Drugs
Pfizer is committed to the weight loss market. They see it as a major growth area. The company has invested heavily in research and development. They are also exploring combinations of drugs to improve results.
One possibility is a drug that targets both GLP-1 and another hormone called GIP. This is similar to Mounjaro, which is very effective. Pfizer has not announced such a drug yet, but it is a logical next step.
Another possibility is a once-weekly pill. This would be even more convenient than daily dosing. Pfizer is working on long-acting formulations that could make this possible.
How To Stay Updated On Pfizer’s Progress
If you want to follow Pfizer’s weight loss drug development, you can check their website. They publish updates on clinical trials and press releases. You can also follow news from the FDA and medical journals.
Your doctor might also know about new developments. They can tell you if a Pfizer drug becomes available in your area. For now, the best advice is to be patient and focus on proven treatments.
Frequently Asked Questions
Does Pfizer make a weight loss drug that is FDA approved?
No, Pfizer does not have any FDA-approved weight loss drugs. Their candidates are still in clinical trials and not available to the public.
What is the name of Pfizer’s weight loss pill?
Pfizer’s main weight loss pills are danuglipron and lotiglipron. Both are experimental and not yet approved for sale.
When will Pfizer’s weight loss drug be available?
There is no confirmed date. If trials succeed, the earliest possible approval might be 2026 or later. Delays are common in drug development.
Is Pfizer’s weight loss drug better than Ozempic?
It is too early to say. Pfizer’s drugs are pills, which is more convenient, but they have not proven to be as effective as Ozempic in large trials.
Can I buy Pfizer’s weight loss drug now?
No, you cannot. Pfizer’s weight loss drugs are only available in clinical trials. You must be a participant to access them.
Pfizer is working hard to bring a weight loss drug to market, but they are not there yet. Their pills could be a game-changer if they work well and have fewer side effects. For now, you have to wait and see. Talk to your doctor about the best options for your health today.